Navigation

Ankylosing spondylitis - golimumab

Golimumab for the treatment of ankylosing spondylitis

Status: History
Expected date of issue: August 2011
Referral date: November 2008
Process: STA
Notes:

The discussion of golimumab for the treatment of ankylosing spondylitis at the Technology Appraisal Committee meeting of 17th November has been cancelled. This is because errors were discovered in the submitted analyses that could not be rectified before the meeting. It is essential that the Appraisal Committee have access to the most robust analyses in order to formulate their preliminary recommendation, so the manufacturer of golimumab regretfully decided to withdraw their submission. The appraisal will be rescheduled at the earliest opportunity.

Topic area:
  • Musculoskeletal
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Helen Tucker
Communications manager: Tonya Gillis
Project manager: Bijal Joshi
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 18th August 2010
1st appraisal committee meeting: 18 May 2011
2nd appraisal committee meeting 19 July 2011
Top


 

Consultees and commentators

 

Consultees

 

Commentators (no right to submit or appeal)

 

Manufacturers/sponsors

  • Schering-Plough (golimumab)

Patient/carer groups

  • Action on Pain
  • Afiya Trust
  • Arthritic Association
  • Arthritis & Musculoskeletal Alliance (ARMA)
  • Arthritis Care
  • BackCare
  • Black Health Agency
  • Brain and Spine Foundation
  • Chinese National Healthy Living Centre
  • Coalition of Ankylosing Spondylitis Patients
  • Counsel and Care
  • Equalities National Council
  • Leonard Cheshire Disability
  • Muslim Council of Great Britain
  • Muslim Health Network
  • National Ankylosing Spondylitis Society
  • Pain Concern
  • Pain Relief Foundation
  • Royal Association for Disability & Rehabilitation (RADAR)
  • South Asian Health Foundation
  • Specialised Healthcare Alliance

Professional groups

  • British Association for Services to the Elderly
  • British Association of Occupational Therapists
  • British Geriatrics Society
  • British Health Professionals in Rheumatology
  • British Institute of Musculoskeletal Medicine
  • British Orthopaedic Association
  • British Pain Society
  • British Society for Rheumatology
  • British Society of Rehabilitation Medicine
  • Chartered Society of Physiotherapy
  • College of Occupational Therapists
  • Physiotherapy Pain Association
  • Primary Care Rheumatology Society
  • Royal College of General Practitioners
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians
  • Royal Pharmaceutical Society
  • Royal Society of Medicine ? Intellectual Disabilities Forum
  • United Kingdom Clinical Pharmacy Association

Others

  • Central and Eastern Cheshire PCT
  • Department of Health
  • Hillingdon PCT
  • Welsh Assembly Government

General

  • Board of Community Health Councils in Wales
  • British National Formulary
  • Care Quality Commission
  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Medicines and Healthcare products Regulatory Agency
  • National Association of Primary Care
  • Public Health Wales NHS Trust
  • NHS Alliance
  • NHS Commercial Medicines Unit
  • NHS Confederation
  • NHS Quality Improvement Scotland
  • Scottish Medicines Consortium

Comparator manufacturer(s)

  • Abbott Laboratories (adalimumab)
  • Pfizer (etanercept)

Relevant research groups

  • Arthritis Research Campaign
  • Bone Research Society
  • Chronic Pain Policy Coalition
  • Cochrane Musculoskeletal Group
  • MRC Clinical Trials Unit
  • National Institute for Health Research
  • Policy Research Institute on Ageing and Ethnicity
  • Research Institute for the Care of Older People
  • Society for Back Pain Research

Evidence Review Group

  • West Midlands Health Technology Assessment Collaboration
  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • National Collaborating Centre for Chronic Conditions

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated: 24 August 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.